Latest period
$13.58B
YoY change
+2065.6%
5Y CAGR
+14.9%
Peak year (2025)
$8.97B
Latest annual
$8.97B
Free Cash Flow history chart for Eli Lilly (LLY) from 1989 to 2025
Latest: $8.97B
Free Cash Flow growth chart for Eli Lilly (LLY) from 1989 to 2025
Latest: +2065.6%
Free Cash Flow history table for Eli Lilly (LLY) from 1989 to 2025
| 2025 | $8.97B | +2065.6% | +$8.56B | ||
| 2024 | $414.30M | -113.1% | +$3.57B | ||
| 2023 | −$3.15B | -168.5% | −$7.75B | ||
| 2022 | $4.60B | -14.6% | −$787.10M | ||
| 2021 | $5.39B | +20.5% | +$917.00M | ||
| 2020 | $4.47B | +28.3% | +$987.40M | ||
| 2019 | $3.48B | +39.0% | +$976.80M | ||
| 2018 | $2.51B | -27.4% | −$945.70M | ||
| 2017 | $3.45B | -8.2% | −$307.00M | ||
| 2016 | $3.76B | +180.9% | +$2.42B | ||
| 2015 | $1.34B | -53.7% | −$1.55B | ||
| 2014 | $2.89B | -37.7% | −$1.75B | ||
| 2013 | $4.64B | +8.9% | +$381.10M | ||
| 2012 | $4.26B | -23.1% | −$1.28B | ||
| 2011 | $5.54B | -2.3% | −$128.50M | ||
| 2010 | $5.67B | +62.9% | +$2.19B | ||
| 2009 | $3.48B | -45.2% | −$2.87B | ||
| 2008 | $6.35B | +55.9% | +$2.28B | ||
| 2007 | $4.07B | +40.5% | +$1.17B | ||
| 2006 | $2.90B | +370.9% | +$2.28B | ||
| 2005 | $615.50M | -36.6% | −$355.90M | ||
| 2004 | $971.40M | -49.9% | −$968.70M | ||
| 2003 | $1.94B | +106.4% | +$1.00B | ||
| 2002 | $939.80M | -66.2% | −$1.84B | ||
| 2001 | $2.78B | -9.0% | −$276.00M | ||
| 2000 | $3.05B | +46.0% | +$962.20M | ||
| 1999 | $2.09B | -5.4% | −$118.50M | ||
| 1998 | $2.21B | +8.6% | +$175.80M | ||
| 1997 | $2.03B | +31.4% | +$486.60M | ||
| 1996 | $1.55B | +21.5% | +$274.20M | ||
| 1995 | $1.27B | +33.2% | +$317.50M | ||
| 1994 | $955.80M | +8.2% | +$72.40M | ||
| 1993 | $883.40M | +83.5% | +$402.00M | ||
| 1992 | $481.40M | +329.1% | +$369.20M | ||
| 1991 | $112.20M | -76.0% | −$354.90M | ||
| 1990 | $467.10M | -2.3% | −$11.00M | ||
| 1989 | $478.10M | — | — |
- 2025$8.97B+2065.6%
- 2024$414.30M-113.1%
- 2023−$3.15B-168.5%
- 2022$4.60B-14.6%
- 2021$5.39B+20.5%
- 2020$4.47B+28.3%
- 2019$3.48B+39.0%
- 2018$2.51B-27.4%
- 2017$3.45B-8.2%
- 2016$3.76B+180.9%
- 2015$1.34B-53.7%
- 2014$2.89B-37.7%
- 2013$4.64B+8.9%
- 2012$4.26B-23.1%
- 2011$5.54B-2.3%
- 2010$5.67B+62.9%
- 2009$3.48B-45.2%
- 2008$6.35B+55.9%
- 2007$4.07B+40.5%
- 2006$2.90B+370.9%
- 2005$615.50M-36.6%
- 2004$971.40M-49.9%
- 2003$1.94B+106.4%
- 2002$939.80M-66.2%
- 2001$2.78B-9.0%
- 2000$3.05B+46.0%
- 1999$2.09B-5.4%
- 1998$2.21B+8.6%
- 1997$2.03B+31.4%
- 1996$1.55B+21.5%
- 1995$1.27B+33.2%
- 1994$955.80M+8.2%
- 1993$883.40M+83.5%
- 1992$481.40M+329.1%
- 1991$112.20M-76.0%
- 1990$467.10M-2.3%
- 1989$478.10M—
Free Cash Flow values are taken from Eli Lilly's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Eli Lilly (LLY)
Free Cash Flow for Eli Lilly (LLY): headline value $13.58B · YoY +2065.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Eli Lilly (LLY) reported free cash flow of $8.97B – surged 2065.6% year-over-year.
Through 2020–2025 (5 years), Eli Lilly free cash flow delivered a +14.9% annualised rate; sustaining 2 straight years of year-over-year growth.
The highest annual free cash flow of $8.97B was reported in 2025. The lowest in the available history was −$3.15B in 2023.
Eli Lilly Free Cash Flow by Year
Eli Lilly Free Cash Flow 2025: $8.97B
Eli Lilly posted free cash flow of $8.97B in 2025, surged 2065.6% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Free Cash Flow 2024: $414.30M
In 2024, Eli Lilly reported free cash flow of $414.30M, plunged 113.1% below 2023.
Eli Lilly Free Cash Flow 2023: −$3.15B
Eli Lilly free cash flow in 2023 was −$3.15B, plunged 168.5% below 2022. This figure represents the lowest annual value in the available history.
Eli Lilly Free Cash Flow 2022: $4.60B
2022's free cash flow for Eli Lilly came in at $4.60B, declined 14.6% below 2021.
Eli Lilly Free Cash Flow 2021: $5.39B
Eli Lilly free cash flow in 2021 was $5.39B.
See more financial history for Eli Lilly (LLY).
Sector peers by Free Cash Flow
Healthcare peers of Eli Lilly (LLY), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.67B | |
| $8.10B | |
| $6.29B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation